Jennifer A Chan Selected Research

Fatigue

10/2020	A phase 2 clinical trial of the heat shock protein 90 (HSP 90) inhibitor ganetespib in patients with refractory advanced esophagogastric cancer.
5/2017	Phase III Prospective Randomized Comparison Trial of Depot Octreotide Plus Interferon Alfa-2b Versus Depot Octreotide Plus Bevacizumab in Patients With Advanced Carcinoid Tumors: SWOG S0518.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jennifer A Chan Research Topics

Disease

58	Neoplasms (Cancer) 11/2022 - 11/2003
18	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2022 - 05/2007
13	Medulloblastoma 01/2022 - 11/2003
11	Brain Neoplasms (Brain Tumor) 06/2022 - 11/2003
10	Colorectal Neoplasms (Colorectal Cancer) 11/2020 - 12/2006
10	Glioma (Gliomas) 10/2020 - 11/2006
9	Glioblastoma (Glioblastoma Multiforme) 10/2021 - 11/2003
7	Carcinogenesis 01/2022 - 12/2006
7	Carcinoid Tumor (Carcinoid) 07/2017 - 06/2011
6	Colonic Neoplasms (Colon Cancer) 01/2015 - 06/2008
4	Primitive Neuroectodermal Tumors (PNET) 01/2022 - 03/2014
4	Neutropenia 01/2019 - 01/2010
4	Astrocytoma (Pilocytic Astrocytoma) 05/2013 - 12/2004
3	Hypertension (High Blood Pressure) 01/2019 - 01/2010
3	Disease Progression 01/2019 - 02/2016
3	Neoplasm Metastasis (Metastasis) 01/2018 - 05/2007
3	Oligodendroglioma 09/2014 - 01/2012
3	Tuberous Sclerosis (Bourneville's Disease) 11/2011 - 12/2004
2	Fatigue 10/2020 - 05/2017
2	Diarrhea 10/2020 - 01/2012
2	Adenocarcinoma 01/2019 - 06/2014
2	Hepatocellular Carcinoma (Hepatoma) 01/2017 - 11/2008
2	Ependymoma 01/2016 - 11/2014
2	Lymphopenia (Lymphocytopenia) 06/2014 - 08/2012
2	Pancreatic Neoplasms (Pancreatic Cancer) 03/2014 - 01/2009
2	Thrombocytopenia (Thrombopenia) 08/2012 - 01/2009
2	Microsatellite Instability 03/2010 - 06/2008
1	Pheochromocytoma 01/2022
1	Paraganglioma (Paragangliomas) 01/2022
1	Body Weight Changes 11/2020
1	Genomic Instability 12/2019
1	Hypersensitivity (Allergy) 01/2019
1	Cerebral Hemorrhage 01/2019

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 01/2020 - 11/2003
8	Everolimus FDA Link 01/2022 - 01/2009
6	Temozolomide (Temodar)FDA LinkGeneric 01/2022 - 05/2009
6	ParaffinIBA 01/2022 - 11/2008
6	Formaldehyde (Formol)FDA Link 01/2022 - 11/2008
6	Bevacizumab (Avastin)FDA Link 01/2022 - 01/2010
6	MicroRNAs (MicroRNA)IBA 02/2016 - 07/2005
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 05/2007
4	NucleotidesIBA 11/2021 - 10/2019
4	RNA (Ribonucleic Acid)IBA 01/2020 - 07/2009
4	Biomarkers (Surrogate Marker)IBA 01/2018 - 01/2012
4	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2017 - 05/2007
4	DNA (Deoxyribonucleic Acid)IBA 01/2016 - 07/2009
3	Pharmaceutical PreparationsIBA 10/2020 - 02/2014
3	Octreotide (Sandostatin)FDA LinkGeneric 05/2017 - 06/2011
3	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 09/2014 - 09/2012
3	trans-sodium crocetinate (crocetin)IBA 11/2011 - 12/2004
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022 - 01/2018
2	AZD 6244IBA 01/2022 - 01/2018
2	ChromatinIBA 10/2021 - 01/2019
2	Cholecalciferol (Vitamin D3)FDA Link 11/2020 - 01/2019
2	Angiogenesis InhibitorsIBA 01/2019 - 08/2011
2	Fluorouracil (Carac)FDA LinkGeneric 01/2019 - 10/2010
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2019 - 01/2010
2	Somatostatin Receptors (Somatostatin Receptor)IBA 09/2018 - 11/2016
2	Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)IBA 01/2018 - 02/2015
2	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2017 - 04/2002
2	pasireotideIBA 01/2017 - 10/2012
2	Biological ProductsIBA 08/2014 - 12/2013
2	Alanine Transaminase (SGPT)IBA 06/2014 - 01/2010
2	Cetuximab (Erbitux)FDA Link 02/2014 - 01/2012
2	Monoclonal AntibodiesIBA 02/2014 - 08/2012
2	ErbB Receptors (EGF Receptor)IBA 02/2014 - 02/2008
2	TOR Serine-Threonine KinasesIBA 09/2013 - 05/2007
2	Sirolimus (Rapamycin)FDA Link 09/2013 - 11/2011
2	Proto-Oncogene Proteins B-rafIBA 05/2013 - 11/2011
2	MTOR InhibitorsIBA 06/2011 - 01/2009
2	Gemcitabine FDA Link 01/2010 - 01/2009
2	beta CateninIBA 09/2009 - 09/2008
2	Streptozocin (Streptozotocin)FDA Link 05/2009 - 05/2007
2	plerixafor FDA Link 11/2006 - 11/2003
1	diethylstilbestrol monophosphate (PDES)IBA 11/2022
1	Untranslated RNA (Noncoding RNA)IBA 01/2021
1	Calcitriol Receptors (Calcitriol Receptor)IBA 11/2020
1	Vitamin D FDA LinkGeneric 11/2020
1	CytokinesIBA 10/2020
1	Interleukin-33IBA 10/2020
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 10/2020
1	STA 9090IBA 10/2020
1	Peptide Elongation Factors (Elongation Factor)IBA 01/2020
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2020
1	U1 small nuclear RNAIBA 10/2019
1	Messenger RNA (mRNA)IBA 01/2019
1	afliberceptIBA 01/2019
1	Leucovorin (Folinic Acid)FDA Link 01/2019
1	hydroxide ionIBA 01/2019
1	25-hydroxyvitamin DIBA 01/2019
1	Antimitotic AgentsIBA 01/2019
1	Immune Checkpoint InhibitorsIBA 10/2018
1	Peptide Receptors (Peptide Receptor)IBA 09/2018
1	lutetium Lu 177 dotatateIBA 09/2018
1	Radioisotopes (Radionuclides)IBA 09/2018

Therapy/Procedure

21	Therapeutics 01/2022 - 11/2006
8	Drug Therapy (Chemotherapy) 01/2022 - 11/2006
5	Adjuvant Chemotherapy 01/2015 - 06/2008
2	Radiotherapy 01/2016 - 11/2014
1	Cranial Irradiation 06/2022